1-6 of 6
Sharlene Gill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

Joao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, Dongsheng Tu, Stephanie Y. Brule, Rachel Goodwin, Derek J. Jonker, Timothy Price, John R. Zalcberg, Malcolm J. Moore, Christos S. Karapetis, Lillian Siu, Jeremy Shapiro, John Simes, Sharlene Gill, Chris J. O'Callaghan, Jonathan M. Loree
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (6): 1121–1130.
https://doi.org/10.1158/1078-0432.CCR-23-3275
Published: 15 March 2024
View article titled, Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials
Open the PDF for Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study

Sharlene Gill, Bruce Colwell, Hal Hirte, Welch Stephen, Alexi Campbell, Desiree Hao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-016.
https://doi.org/10.1158/1557-3265.COVID-19-PO-016
Published: 15 September 2020
View article titled, Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study
Journal Articles

Population-based Screening for BRAFV600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis

Jenny E. Chu, Benny Johnson, Laveniya Kugathasan, Van K. Morris, Kanwal Raghav, Lucas Swanson, Howard J. Lim, Daniel J. Renouf, Sharlene Gill, Robert Wolber, Aly Karsan, Scott Kopetz, David F. Schaeffer, Jonathan M. Loree
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4599–4605.
https://doi.org/10.1158/1078-0432.CCR-20-1024
Published: 01 September 2020
View article titled, Population-based Screening for <em>BRAF</em><sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
Open the PDF for Population-based Screening for <em>BRAF</em><sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis in another window
Includes: Supplementary data
Journal Articles

NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma

Martin R. Jones, Laura M. Williamson, James T. Topham, Michael K.C. Lee, Angela Goytain, Julie Ho, Robert E. Denroche, GunHo Jang, Erin Pleasance, Yaoquing Shen, Joanna M. Karasinska, John P. McGhie, Sharlene Gill, Howard J. Lim, Malcolm J. Moore, Hui-li Wong, Tony Ng, Stephen Yip, Wei Zhang, Sara Sadeghi, Carolyn Reisle, Andrew J. Mungall, Karen L. Mungall, Richard A. Moore, Yussanne Ma, Jennifer J. Knox, Steven Gallinger, Janessa Laskin, Marco A. Marra, David F. Schaeffer, Steven J.M. Jones, Daniel J. Renouf
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4674–4681.
https://doi.org/10.1158/1078-0432.CCR-19-0191
Published: 01 August 2019
View article titled, <em>NRG1</em> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <em>KRAS</em> Wild-Type Pancreatic Ductal Adenocarcinoma
Open the PDF for <em>NRG1</em> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <em>KRAS</em> Wild-Type Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study

Daniel J. Sargent, Qian Shi, Sharlene Gill, Christophe Louvet, Richard B. Everson, Udo Kellner, Thomas E. Clancy, J. Marc Pipas, Murray B. Resnick, Michael O. Meyers, Tsung-Teh Wu, David Huntsman, Pierre Validire, Umar Farooq, Emily S. Pavey, Guillaume Beaudry, Jean-Francois Haince, Yves Fradet
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4361–4369.
https://doi.org/10.1158/1078-0432.CCR-13-2659
Published: 13 August 2014
View article titled, Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study
Open the PDF for Molecular Testing for Lymph Node Metastases as a Determinant of Colon Cancer Recurrence: Results from a Retrospective Multicenter Study in another window
Includes: Supplementary data
Journal Articles

Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation

Sharlene Gill, Noralane M. Lindor, Lawrence J. Burgart, Regenia Smalley, Olga Leontovich, Amy J. French, Richard M. Goldberg, Daniel J. Sargent, Jeremy R. Jass, John L. Hopper, Mark A. Jenkins, Joanne Young, Melissa A. Barker, Michael D. Walsh, Andrew R. Ruszkiewicz, Stephen N. Thibodeau
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6466–6471.
https://doi.org/10.1158/1078-0432.CCR-05-0661
Published: 15 September 2005
View article titled, Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation
Open the PDF for Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation in another window